Pier Luigi Zinzani, MD¹, Felipe Samaniego, MD², Wojciech Jurczak, MD, PhD³, Nilanjan Ghosh, MD, PhD⁴, Enrico Derenzini, MD, PhD^5*, James A Reeves, MD^6*, Wanda Knopinska-Posluszny, MD, PhD^7*, Chan Yoon Cheah, MBBS⁸, Tycel J. Phillips, MD⁹, Ewa Lech-Marańda, MD, PhD^10*, Bruce D. Cheson, MD¹¹, Paolo F Caimi, MD¹², Sebastian Grosicki, MD, PhD¹³, Lori A. Leslie, MD¹⁴, Julio C. Chavez, MD¹⁵, Gustavo A. Fonseca, MD¹⁶, Sunil Babu^17*, Daniel J. Hodson, MD, PhD¹⁸, Spencer H. Shao, MD¹⁹, John M. Burke, MD²⁰, Jeff P Sharman, MD²¹, Jennie Y. Law, MD²², John M. Pagel, MD PhD²³, Owen A. O'Connor, MD, PhD²⁴, Hari P. Miskin, MSc^25*, Peter Sportelli, BS ²⁵, Michael S. Weiss^25* and Nathan H Fowler, MD²

¹Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
²Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁴Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC
⁵Hematoncology Division, European Institute of Oncology IRCCS, MILANO, Italy
⁶Florida Cancer Specialists South / Sarah Cannon Research Institute, Fort Myers, FL
⁷Gdynia Oncology Center, Gdynia, Poland
⁸Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
⁹University of Michigan Comprehensive Cancer Center, Dexter, MI
¹⁰Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹¹Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
¹²Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
¹³Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
¹⁴John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁵H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁶Florida Cancer Specialists, St Petersburg, FL
¹⁷Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN
¹⁸Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
¹⁹Compass Oncology / US Oncology Research, Portland, OR
²⁰US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
²¹Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR
²²Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²³Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
²⁴Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
²⁵TG Therapeutics, Inc., New York, NY

Ryan C. Lynch, MD^1*, Shankara Paneesha, MD², Abraham Avigdor, MD^3,4, Matthew S McKinney^5*, Björn E Wahlin, MD, PhD⁶, John S Hrom^7*, David Belada, MD, PhD^8*, Miguel Canales^9*, David Cunningham, MD, FRCP, FMedSci^10*, Liliana Devizzi^11*, Nicholas Morley^12*, Fred Zheng, MD^13*, Douglas J DeMarini, PhD^13*, Wei Jiang, PhD^13* and Marek Trněný, MD¹⁴

¹Seattle Cancer Care Alliance, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, Birmingham, United Kingdom
³Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⁴Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁵Duke Cancer Institute, Durham, NC
⁶Karolinska Institutet, Department of Medicine, Huddinge, and Karolinska University Hospital, Unit for Hematology, Stockholm, Sweden
⁷Forrest General Hospital and Hattiesburg Clinic, Hattiesburg, MS
⁸4th Department of Internal Medicine – Hematology, University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
⁹Hospital Universitario La Paz, Madrid, Spain
¹⁰Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom
¹¹Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
¹²Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, United Kingdom
¹³Incyte Corporation, Wilmington, DE
¹⁴First Department of Medicine – Hematology, Charles University General Hospital, Prague, Czech Republic

Reid W Merryman, MD¹, Gabriela Spilberg, MD^2*, Patrizia Mondello, MD, PhD, MSc³, Robert A. Redd, MS^4*, Eleanor Taranto, MD^5*, Gulrayz Ahmed, MD^6*, Erin Jeter^1*, Matthew Chase, MD^7*, Gilles Salles, MD, PhD⁸, Andrew D Zelenetz, MD, PhD⁸, Jennifer R Brown, MD, PhD¹, Jennifer Crombie, MD^1*, Matthew S. Davids, MD¹, David C. Fisher, MD^1*, Arnold S. Freedman, MD¹, Eric D Jacobsen, MD¹, Caron A. Jacobson, MD^1*, Austin I. Kim, MD⁹, Ann S. LaCasce, MD, MSc¹, Benjamin L. Lampson, MD, PhD¹, Samuel Y. Ng, MD, PhD¹, Oreofe Odejide, MD^1*, Philippe Armand, MD, PhD¹ and Heather A. Jacene, MD^10*

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Jefferson Radiology, Hartford, CT
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Beth Israel Deaconess Medical Center, Boston, MA
⁸Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁰Department of Imaging, Dana-Farber Cancer Institute, Boston, MA

Judith Trotman, FRACP¹, Christian Buske, MD², Alessandra Tedeschi, MD^3*, Jeffrey V. Matous, MD⁴, David MacDonald, MD⁵, Constantine Tam, MBBS⁶, Olivier Tournilhac, MD, PhD^7*, Shuo Ma, MD, PhD⁸, Steven P. Treon, MD, PhD⁹, Albert Oriol^10*, Jerry Ping, PhD^11*, Eva M. Briso, PhD^12*, Israel Arango-Hisijara, MD^11* and Meletios A. Dimopoulos, MD¹³

¹Concord Hospital, Concord, Australia
²Comprehensive Cancer Center Ulm, Ulm, Germany
³Niguarda Hospital, Milano, Italy
⁴Colorado Blood Cancer Institute, Denver, CO
⁵The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
⁶Peter MacCallum Cancer Centre and St. Vincent’s Hospital and the University of Melbourne, Melbourne, VIC, Australia
⁷Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France
⁸Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹¹Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
¹²Pharmacyclics Switzerland GmbH, an AbbVie Company, Schaffhausen, Switzerland
¹³National and Kapodistrian University of Athens School of Medicine, Athens, Greece

Constantine S. Tam, MD¹, Radhakrishnan Ramchandren, MD², Robert Chen, MD³, Lionel Karlin, MD^4*, Geoffrey Chong, MD⁵, Wojciech Jurczak, MD, PhD⁶, Ka Lung Wu, MD, PhD⁷, Mark Bishton, MBChB, MRCP, FRCPath, PhD^8*, Graham P. Collins, MD, DPhil⁹, Paul Eliadis, MBBS, FRACP, FRCPA^10*, Frédéric Peyrade, MD^11*, Edith Szafer-Glusman, PhD^12*, Yihua Lee, PhD^12*, Karl Eckert, BA^12*, Jutta K. Neuenburg, MD, PhD¹² and Michael Wang, MD¹³

¹Peter MacCallum Cancer Centre, Royal Melbourne Hospital, St Vincent’s Hospital and University of Melbourne, Melbourne, Australia
²University of Tennessee, Knoxville, TN
³City of Hope National Medical Center, Duarte, CA
⁴Centre Hospitalier Lyon Sud, Lyon, France
⁵Olivia Newton-John Cancer Centre, Heidelberg, Australia
⁶Sklodowska Curie National Research Institute of Oncology, Krakow, Poland
⁷Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
⁸Nottingham University Hospitals, Nottingham, United Kingdom
⁹Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
¹⁰Icon Cancer Centre South Brisbane, South Brisbane, Australia
¹¹Centre Antoine Lacassagne, Nice Cedex, France
¹²Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
¹³Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Jean-Marie Michot Jr., MD^1*, Reda Bouabdallah, MD^2*, Jeanette K. Doorduijn, MD, PhD³, Carola Boccomini, MD^4*, Marie José Kersten, MD, PhD⁵, Annalisa Chiappella⁶, Pier Luigi Zinzani, MD⁷, Gilles Salles, MD, PhD⁸, Fontanet Bijou, MD^9*, Mei Hentrup, BSN, BS^10*, So Hyun Rhee, PharmD^10*, Patrick Hagner, PhD^10*, Christian Klein, PhD¹¹, Michael Pourdehnad^10*, Kristen Hege, MD¹⁰, Juergen Dobmeyer, MD^12*, Zariana Nikolova, MD, PhD¹² and Vincent Ribrag, MD¹

¹Institut Gustave Roussy, Villejuif, France
²Institut Paoli-Calmettes, Marseille, France
³Erasmus MC Cancer Institute; on behalf of the HOVON/Lunenburg Lymphoma Phase I/II Consortium (HOVON/LLPC), Rotterdam, Netherlands
⁴Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy
⁵Amsterdam University Medical Centers; on behalf of the HOVON/Lunenburg Lymphoma Phase I/II Consortium (HOVON/LLPC), Amsterdam, Netherlands
⁶Città della Salute Hospital and University, Torino, Italy; Present affiliation: IRCCS Foundation, Istituto Nazionale dei Tumori, Milano, Italy
⁷Institute of Hematology "L. and A. Seràgnoli," University of Bologna, Bologna, Italy
⁸Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
⁹Institut Bergonié, Bordeaux Cedex, France
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Roche Innovation Center, Zurich, Switzerland
¹²Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain

Gang An, MD, PhD^1*, Daobin Zhou, MD, PhD^2*, Weili Zhao, MD, PhD³, Keshu Zhou, MD, PhD^4*, Jianyong Li, MD, PhD⁵, Jianfeng Zhou, MD, PhD^6*, Liping Xie, MD, PhD^7*, Jie Jin, MD, PhD⁸, Liye Zhong, MD, PhD^9*, Lingzhi Yan, MD, PhD^10*, Haiyi Guo, MD^11*, Chenmu Du, MD^11*, Jane Huang, MD^12*, William Novotny, MD^12*, Jinhua Zhong, PhD^13* and Lugui Qiu, MD¹⁴

¹Department of Lymphoma, Chinese Academy of Medical Sciences, Blood Diseases Hospital (Institute of Hematology), Tianjin, China
²Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
³Department of Hematology, Shanghai Ruijin Hospital, Shanghai, China
⁴Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁵Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁶Department of Hematology, Tongji Hospital, Tongji Medical College, Wuhan, China
⁷Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
⁸Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
⁹Department of Hematology, Guangdong Provincial People’s Hospital, Guangzhou, China
¹⁰Department of Hematology, The First Affiliated Hospital of Soochow University, Soochow, China
¹¹BeiGene Co., Ltd., Beijing, China
¹²BeiGene USA, Inc., San Mateo, CA
¹³BeiGene Co., Ltd., Shanghai, China
¹⁴National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Ning Dong, MD^1,2, Hayder Saeed, MD³, Leidy Isenalumhe, MD¹, Franco Castillo Tokumori, MD^2*, Bijal Shah, MD¹, Sameh Gaballa, MD^1*, Celeste Bello, MD¹, Lubomir Sokol, MD, PhD¹, Javier Pinilla Ibarz, MD, PhD¹ and Julio C. Chavez, MD¹

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²University of South Florida, Tampa
³H. Lee Moffitt Cancer Center, Tampa, FL

Hun Ju Lee, MD¹, Michael Y. Choi, MD², Tanya Siddiqi, MD^3*, William G. Wierda, MD, PhD⁴, Jacqueline C. Barrientos, MD⁵, Nicole Lamanna, MD⁶, Alec Goldenberg, MD^7*, Iris Isufi, MD⁸, Joseph Tuscano, MD^9*, Suki Subbiah, MD¹⁰, Jean L. Koff, MD¹¹, Lori A. Leslie, MD¹², Gina G Chung, MD^13*, Elizabeth K Weihe, MD^2*, Xen Ianopulos, MD, PhD^14*, James B. Breitmeyer, MD, PhD¹⁴, Frank J Hsu, MD¹⁴, Michael Wang, MD¹⁵, Catriona Jamieson, MD, PhD² and Thomas J. Kipps, MD, PhD²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Moores Cancer Center, University of California, San Diego, La Jolla, CA
³City of Hope National Medical Center, Duarte, CA
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Karches Center for Oncology Research, The Feinstein Institute for Medical Research, Manhasset, NY
⁶New York-Presbyterian/ Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY
⁷Manhattan Hem Onc Associates, New York, NY
⁸Hematology, Yale University School of Medicine, New Haven, CT
⁹Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, Sacramento, CA
¹⁰LSU Health Sciences Center, New Orleans, LA
¹¹Division of Bone Marrow and Stem Cell Transplantation, Winship Cancer Institute of Emory University, Atlanta, GA
¹²Lymphoma Research Division, John Theurer Cancer Center, Hackensack, NJ
¹³The Christ Hospital, Lindner Center for Research and Education, Cincinnati, OH
¹⁴Oncternal Therapeutics, San Diego, CA
¹⁵Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Chaitra S. Ujjani, MD¹, Catherine Lai, MD, MPH², Lori A. Leslie, MD³, Pari Ramzi, RN^2*, Ming Tan^4*, Siyu Wang^2*, Hongkun Wang^2*, Eunice Shim^2*, Nicole Swanson^2*, Catherine M Broome², Ajay K. Gopal, MD¹, Stephen D. Smith, MD¹, Edus H. Warren, MD, PhD¹, Katie Blue^1*, Sabrina Kdiry, BSN^3*, Brian G. Till, MD¹, Ryan C. Lynch, MD^1*, Mazyar Shadman, MD, MPH^1*, Michael Johnson^2*, Hilary Coye, PA-C^1*, Megan Shelby, PA-C^1*, Yolanda D. Tseng, MD^1*, Andrei Shustov, MD^1*, David G. Maloney, MD, PhD¹ and Bruce D. Cheson, MD²

¹University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
²Georgetown University Hospital/Lombardi Comprehensive Cancer Center, Washington, DC
³Hackensack University Medical Center/ John Theuer Cancer Center, Hackensack, NJ
⁴Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Hospital/Lombardi Comprehensive Cancer Center, Washington, DC

Kate Manos, MBBS¹, Masa Lasica, MD^2*, Andrew Grigg, MBBS, MD, FRACP, FRCPA^1*, Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA³, Jonathan Wong, MBBS^4,5, Usha Chandra Sekaran^6*, Joel Wight^1,7,8, Zhong Goh^9*, Hayden Jina^10*, Llewyn Butler^11*, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA^12*, Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA^13,14, Gareth P. Gregory^4,15, Shane A Gangatharan, MBBS, FRACP, FRCPA ^6,16,17, Tara Cochrane, MBBS, FRCPA, FRACP¹⁸, Kristen Piper^19*, Leonid Churilov^20* and Eliza A Hawkes, FRACP, MD, MBBS^21,22

¹Department of Haematology, Austin Health, Melbourne, Australia
²St Vincent's Hospital, Melbourne, VIC, AUS
³Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia
⁴Department of Haematology, Monash Health, Clayton, Australia
⁵School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia
⁶Fiona Stanley Hospital, Murdoch, Australia
⁷Townsville University Hospital, Douglas, Australia
⁸University of Melbourne, Melbourne, Australia
⁹Gold Coast University Hospital, Southport, Australia
¹⁰Eastern Health, Box Hill, Australia
¹¹St Vincent's Hospital, Fitzroy, Australia
¹²Epworth HealthCare, East Melbourne, VIC, Australia
¹³Faculty of Medicine, University of New South Wales, Sydney, Australia
¹⁴Department of Haematology, St Vincent's Hospital, Sydney, Australia
¹⁵School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
¹⁶University of Western Australia, Nedlands, Australia
¹⁷Fremantle Hospital, Nedlands, WEA, AUS
¹⁸Department of Hematology, Gold Coast University Hospital, Southport, Australia
¹⁹St Vincent's Hospital, Sydney, Australia
²⁰Melbourne Brain Centre, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
²¹Austin Health, Heidelberg, VIC, Australia
²²Department of Medical Oncology and Haematology, Eastern Health, Box Hill, Australia

Grzegorz S. Nowakowski, MD¹, Lori A. Leslie, MD^2*, Erel Joffe, MD, MSc³, Allison C. Rosenthal, D.O.⁴, Matthew A. Lunning, DO, FACP⁵, Krish Patel, MD⁶, Monica Mead, MD, BS⁷, Daniel J. Landsburg, MD⁸, Timothy S. Fenske, MD⁹, Radhakrishnan Ramchandren¹⁰, Praveen Ramakrishnan Geethakumari, MD, MS¹¹, Alan Skarbnik, MD¹², Elizabeth Martinez, PhD, DHSC, MSN^13*, Christopher Lieberman^14*, Reinhard von Roemeling, MD¹⁵ and Han W. Tun, MD¹⁶

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Mayo Clinic, Phoenix, AZ
⁵University of Nebraska Medical Center, Omaha, NE
⁶Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
⁷Department of Hematology/Oncology, UCLA Medical Center, Santa Monica, CA
⁸Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁹Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁰University of Tennessee, Knoxville, TN
¹¹Harold C. Simmons Comprehensive Cancer Center, Dallas, TX
¹²Novant Health, Charlotte, NC
¹³Curis Inc., Lexington, MA
¹⁴Curis, Inc, Lexington, MA
¹⁵Curis, Inc., Lexington, MA
¹⁶Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL

Andrew Hsu, MD^1,2, Adam Zayac, MD^1,2, Habibe Kurt, MD^3,4* and Adam J Olszewski, MD^1,5

¹Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
²Department of Medicine, Alpert Medical School of Brown University, Providence, RI
³Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, RI
⁴Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Providence, RI
⁵Brown University, Providence, RI

Mazyar Shadman, MD, MPH^1*, Jeff P Sharman, MD², Moshe Y. Levy, MD³, Jamal Misleh, MD^4*, Syed F. Zafar, MD⁵, Benjamin B. Freeman, MD^6*, John M. Burke, MD⁷, Jennifer L. Cultrera, MD^8*, Habte A. Yimer, MD⁹, Dih-Yih Chen, MD^10*, Xiaoping Zhang, MD^10*, Aileen Cohen, MD, PhD^10*, Sunhee Ro, PhD^10*, Jane Huang, MD^10* and Ian W. Flinn, MD, PhD¹¹

¹Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
²Willamette Valley Cancer Institute and Research Center, Eugene, OR
³Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
⁴Medical Oncology Hematology Consultants PA, Newark, DE
⁵Florida Cancer Specialists & Research Institute, Fort Myers, FL
⁶Summit Medical Group, Florham Park, NJ
⁷Rocky Mountain Cancer Centers, Aurora, CO
⁸Florida Cancer Specialists & Research Institute, Leesburg, FL
⁹Texas Oncology-Tyler, Tyler, TX
¹⁰BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
¹¹Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN

Oliver Tomkins, BMBS, MRCP^1*, Jindriska Lindsay, FRCPath^2*, Stephen Keddie, MRCP^3*, Aisling Carr, PhD FRCP^4*, Helen McCarthy, PhD, FRCPath^5*, Dima El-Sharkawi, MBBS, FRCPath, PhD^6*, Charalampia Kyriakou, MD, PhD^1,7, Kirsty Cuthill, FRCPath, MBBS, MRCP, PhD^8*, Guy Pratt, FRCPath⁹, Ali Rismani, FRCPath^1*, Michael P Lunn^4* and Shirley D'Sa, MD, FRCPath^10*

¹University College London Hospitals NHS Foundation Trust, London, United Kingdom
²East Kent Hospitals University NHS Foundation Trust, Canterbury, ENG, GBR
³Peripheral Nerve Service, National Hospital for Neurology and Neurosurgery, London, United Kingdom
⁴National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom
⁶Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁷London North West University Healthcare NHS Trust and University College London Hospital, London, United Kingdom
⁸King's College Hospital NHS Foundation Trust, London, United Kingdom
⁹Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
¹⁰UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom

Ryu Lv^1*, Yi Wang^2*, Tingyu Wang^3*, Xiong Wenjie^4*, Huijun Wang^5*, Yuting Yan^6*, Qi Wang^7*, Wei Liu^8*, Gang An, MD, PhD^9*, Wenyang Huang^6*, Weiwei Sui, MD^10*, Yan Xu, MD^11*, Zhen Yu, MD^5*, Dehui Zou, MD^12*, Jianxiang Wang, MD⁵, Lugui Qiu, MD⁶ and Shuhua Yi, MD^5*

¹lymphoma and myeloma center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
³Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁴Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁷Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
⁹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin City, China
¹⁰Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
¹¹The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹²Lymphoma Center, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Hematology and Blood Diseases Hospital (IH), Tianjin, China

Dai Chihara, MD, PhD¹, Melissa C. Larson, MS^2*, Dennis P. Robinson^2*, Carrie A. Thompson, MD³, Matthew J. Maurer, MS^2*, Carla Casulo, MD⁴, Brian K. Link, MD⁵, Thomas M. Habermann, MD³, Andrew L. Feldman, MD⁶, Christopher Flowers, MD, MS⁷, James R. Cerhan, MD, PhD² and Lindsay M. Morton, PhD⁸

¹Medical Oncology Service, National Institute of Health, Bethesda, MD
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Medicine , Hematology/Oncology, James P. Wilmot Cancer Center, Rochester, NY
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁷Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD

Mats Jerkeman, MD, PhD¹, Thorgerdur Palsdottir^2*, Ingrid Glimelius, MD, PhD^3*, Alexandra Albertsson-Lindblad, MD, PhD^4*, Caroline Weibull^5*, Fredrik Ellin, MD, PhD^6*, Kristina Sonnevi, MD, PhD^7*, Catharina Lewerin, MD, PhD^8*, Lena Brandefors^9* and Karin E. Smedby, MD, PhD^10*

¹Department of Oncology, Skane University Hospital, Lund, Skaane Laen, Sweden
²Clinical Epidemiology, Karolinska Institute, Stockholm, Sweden
³Department of Immunology, Genetics and Pathology, Unit of Oncology, Uppsala University, Uppsala, Sweden
⁴Dept of Oncology, Institute of Clinical Sciences, Lund University, Lund, Sweden
⁵Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁶Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden
⁷Karolinska Institutet Univeristy Hospital, Stockholm, SWE
⁸Sahlgrenska University Hospital, Goeteborg, Sweden
⁹Sunderby Sjukhus, Lulea, SWE
¹⁰Karolinska University Hospital, Stockholm, Sweden

Krish Patel, MD^1*, Neil Bailey, MSc^2* and John M. Pagel, MD, PhD¹

¹Swedish Cancer Institute, Seattle, WA
²Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA

Yazeed Sawalha, MD¹, Subir Goyal, PhD^2*, Jeffrey M. Switchenko, PhD, MS^3*, Jason T. Romancik, MD⁴, Manali Kamdar, MD⁵, Irl Brian Greenwell, MD⁶, Brian T. Hess, MD⁷, Krista Isaac, DO, MS⁸, Craig A. Portell, MD⁹, Alex V. Mejia Garcia, MD¹⁰, Scott R. Goldsmith, MD¹¹, Natalie S Grover, MD¹², Peter A. Riedell, MD¹³, Reem Karmali, MD, MSc¹⁴, Madelyn Burkart, MD^15*, Michael J Buege, PharmD¹⁶, Othman S. Akhtar, MD¹⁷, Pallawi Torka, MD^18*, Anita Kumar, MD¹⁹, Brian T. Hill, MD²⁰, Brad S. Kahl, MD²¹ and Jonathon B. Cohen, MD, MS²²

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA
³Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA
⁴Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA
⁵Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
⁶Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁷Division of Hematology and Medical Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC
⁸Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA
⁹Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
¹⁰Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
¹¹Division of Oncology, Washington University, Rock Hill, MO
¹²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
¹³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁴Division of Hematology Oncology, Northwestern University, Chicago, IL
¹⁵Northwestern University; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, IL
¹⁶Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Department of Medicine, State University of New York at Buffalo, Buffalo, NY
¹⁸Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering, Short Hills, NJ
²⁰Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²¹Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MO
²²Winship Cancer Institute, Emory University, Atlanta, GA

Mujtaba Soniwala, DO¹, Saadia Sherazi, MBBS, MS^2*, Susan Schleede, MS^3*, Scott McNitt, MS^3*, Tina Faugh^4*, Jeremiah Moore, PharmD^5*, Justin Foster, PharmD^3*, Clive S. Zent, MD⁶, Paul M. Barr, MD⁶, Patrick M. Reagan, MD⁷, Jonathan W. Friedberg, MD, MSSc⁶, Eugene Storozynsky, MD PhD^3*, Ilan Goldenberg, MD^3* and Carla Casulo, MD⁶

¹Department of Medicine, University of Rochester Medical Center, Rochester, NY
²Department of Medicine, University of Rochester Medical Center, Rochester
³University of Rochester Medical Center, Rochester
⁴Wilmot Cancer Insitute, University of Rochester Medical Center, Rochester
⁵Wilmot Cancer Institute Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
⁶Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁷Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY

Amulya Yellala, MBBS^1,2, Elizabeth R. Lyden, MS^3*, Heather Nutsch^4*, Avyakta Kallam, MD⁵, Kai Fu, MD, PhD⁶, Timothy C. Greiner, MS, MD⁷, Philip Bierman, MD⁸, Matthew A. Lunning, DO, FACP⁵, R. Gregory Bociek, MD⁵, James O. Armitage, MD⁹ and Julie M. Vose, MD, MBA⁹

¹Department of Hematology and Oncology, University Of Nebraska Medical Center, Omaha
²Department of Hematology and Oncology, University Of Nebraska Medical Center, Omaha, NE
³Department of Biostatistics, College of Public Health, Omaha
⁴University of Nebraska Medical Center, Omaha
⁵University of Nebraska Medical Center, Omaha, NE
⁶Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE
⁷Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
⁸Univ. of Nebraska Medical Center, Omaha, NE
⁹Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE

Åsa Lindberg III^1*, Christian Winther Eskelund^2*, Alexandra Albertsson-Lindblad, MD, PhD^3*, Arne Kolstad, MD, PhD^4*, Anna Laurell, MD, PhD^5*, Riikka Räty, MD, PhD^6*, Kirsten Grønbæk, Prof, MD, DMSc^7,8,9,10, Christian H. Geisler, MD, PhD¹¹ and Mats Jerkeman, MD, PhD^12,13,14,15

¹Halmstad County Hospital, Halmstad, Sweden
²Copenhagen University Hospital, Copenhagen, Denmark
³Dept of Oncology, Institute of Clinical Sciences, Lund University, Lund, Sweden
⁴Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
⁵University Hospital Uppsala, Uppsala, SWE
⁶Department of Hematology, Helsinki University Hospital, HUS, FIN
⁷Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
⁸The Epi-/Genome Laboratory, Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁹Dep, Rigshospitalet, Copenhagen, Denmark
¹⁰Department of Hematology, Rigshospitalet, Copenhagen, Denmark
¹¹Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
¹²Dept of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Lund, Sweden
¹³Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
¹⁴Lund University, Stockholm, Sweden
¹⁵Department of Oncology, Skane University Hospital, Lund, Skaane Laen, Sweden

Ilseung Choi, MD^1*, Masaya Okada, MD^2* and Tomoki Ito, MD, PhD^3*

¹Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-City, FKO, Japan
²Division of Hematology, Department of Internal Medicine, Hyogo College Of Medicine, nishinomiya city, Japan
³1st. Department of internal medicine, Kansai Medical University, Hirakata, Japan

Suzanne O Arulogun, MBBS¹, Duncan Brian^2*, Harshita Goradia^3*, Aaron Cooney^4*, Tobias Menne, MD, PhD^5*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS^6,7, Aideen Therese O'Neill, FRCPath^1*, Josephine M.I Vos^8,9*, Guy Pratt, FRCPath¹⁰, Deborah Turner^11*, Kirsty Marshall^12*, Kate Manos, MBBS¹³, Claire Anderson^14*, Maria Gavriatopoulou^15*, Charalampia Kyriakou, MD, PhD¹⁶, Monique C. Minnema¹⁷, Dima El-Sharkawi, MBBS, FRCPath, PhD^18*, Marie José Kersten, MD, PhD¹⁹, RayMun Koo^20*, Helen McCarthy, PhD, FRCPath^21*, Mark Bishton, MBChB, MRCP, FRCPath, PhD^3*, George Follows^2*, Ashutosh D. Wechalekar^22* and Shirley D'Sa, MD, FRCPath^1*

¹University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
³Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁴Royal Bournemouth Hospital, Bournemouth, United Kingdom
⁵Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
⁶Medical School, The Australian National University, Canberra, Australia
⁷Department of Haematology, The Canberra Hospital, Canberra, Australia
⁸Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
⁹Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, Netherlands
¹⁰Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
¹¹Torbay Hospital, Torquay, United Kingdom
¹²The Royal Marsden NHS Foundation Trust, London, United Kingdom
¹³Department of Haematology, Austin Health, Melbourne, Australia
¹⁴Barnet and Chase Farm Hospitals NHS Trust, London, United Kingdom
¹⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁶London North West University Healthcare NHS Trust and University College London Hospital, London, United Kingdom
¹⁷University Medical Center Utrecht, Utrecht, Netherlands
¹⁸Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom
¹⁹Department of Hematology, Amsterdam UMC, University of Amsterdam; LYMMCARE (Lymphoma and Myeloma Center, Amsterdam), and Cancer Center Amsterdam, Amsterdam, Netherlands
²⁰Canberra Health Services, Canberra, Australia
²¹The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom
²²University College London and the Royal Free London NHS Foundation Trust, London, United Kingdom

Lakene Raissa Djoufack Djoumessi, MD^1,2*, Snegha Ananth, MBBS^1,2, Michael E Auster, DO^3*, Joel E Michalek, PhD^4*, Qianqian Liu, PhD^5* and Adolfo Enrique Diaz Duque, MD, MSc^6,7

¹South Texas Veterans Health Care System, San Antonio, TX
²University of Texas Health Science Center San Antonio, San Antonio, TX
³University of Texas Health Science Center at San Antonio, San Antonio
⁴The University of Texas Health Science Center At San Antonio, San Antonio, TX
⁵Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
⁶Hematology-Oncology Division, UT Health Cancer Center at San Antonio, San Antonio, TX
⁷Hematology-Oncology Division, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX

Maria Alejandra Torres Viera, MD^1,2*, Brady E Beltran, MD^3,4*, Luis Villela Villela, MD, MC^5,6*, Denisse A. Castro, MD⁷, Victoria Otero, MD^8*, Lorena Fiad, MD^9*, Camila Peña, MD¹⁰, Henry Idrobo, MD^11,12,13,14*, Myrna Candelaria, MD, PharmD¹⁵, Alana Von Glasenapp, MD^16*, Ivan Perdomo, MD^17*, Maria Virginia Prates, MD⁹, Sally Rose Paredes, MD^18*, Fernando Pérez-Jacobo, MD¹⁹, Ana Ramirez-Ibarguen, MD^20*, Juan Alejandro Ospina Idarraga^21,22*, Maria Elena Cabrera, MD^23*, Claudia Gajardo, MD^24*, Macarena Alejandra Roa Salinas^25*, Catalina Díaz, MD^26*, Laura Silva Idárraga, MD^27*, Humberto Martínez Cordero, MD^28*, Melani Otañez, MD^29*, Fabiola Valvert, MD³⁰, Efreen Montaño Figueroa, MD, PhD^31*, Marcos Di Stefano, MD^32,33*, Rosio Baena, MD^34,35*, Juan Antonio Choque, MD^36*, Virginia Abello, MD^37*, Cristaldo Nancy, MD^38*, Guilherme Fleury Perini^39*, Luis E Malpica Castillo, MD⁴⁰, Eduardo Sotomayor, MD⁴¹ and Jorge J. Castillo, MD^42,43

¹Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of)
²Clinica Santa Sofia, Caracas, Miranda, Venezuela
³Departamento de Oncología y Radioterapia,, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
⁴4Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
⁵Campus Hermosillo, Universidad del Valle de Mexico, Son, Mexico
⁶1) Hospital Dr. Ignacio Chavez, ISSSTESON,Hermosillo,Son,Mex, Hermosillo, SO, Mexico
⁷Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
⁸Sección Hematología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁹Hematología, Hospital Italiano de La Plata, La Plata, Argentina
¹⁰Hematology Department, Hospital Del Salvador, Santiago, Chile
¹¹Facultad de Medicina., Universidad Del Valle, Cali, Colombia
¹²Hospital Universitario del Valle, Cali, Colombia
¹³Facultad de Medicina., Universidad Libre, Cali, Colombia
¹⁴Hematología Oncología, Grupo Ospedale, Cali, Colombia
¹⁵Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico
¹⁶Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
¹⁷Clínica Los Nogales, Bogota, Colombia
¹⁸Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹⁹Hematology Department, Hospital Central Norte Petróleos Mexicanos, Ciudad DE Mexico, Cdmx, Mexico
²⁰Instituto Nacional de Cancerologia, Mexico, Mexico
²¹El Bosque los Cobos Medical Center, Bogotá, Colombia
²²Instituto Nacional de Cancerología, Bogotá, Colombia
²³Hematology Department, Hospital del Salvador, Santiago, Chile
²⁴Hospital del Salvador, Santiago, Chile
²⁵Hematología, Hospital Del Salvador, Santiago, Chile
²⁶Hematología, Hospital del Salvador, Santiago, Chile
²⁷Universidad Libre Seccional de Cal, Cali, Colombia
²⁸Instituto Nacional de Cancerologia, Bogota, Colombia
²⁹Hospital General del Estado de Sonora, Hermosillo, Son., Mexico
³⁰Instituto De Cancerología y Hospital Dr. Bernardo Del Valle (INCAN), Ciudad de Guatemala, Guatemala
³¹Hospital General de Mexico, CDMX, Mexico
³²Hospital Solom Espinosa Ayala, Solca-Quito, Ecuador
³³Hospital de los Valles de Quito, Universidad San Francisco de Quito, Quito, Ecuador
³⁴Clínica Los Olivos, Cochabamba, Bolivia (Plurinational State of)
³⁵Instituto Oncológico Nacional Caja Petrolera de Salud, Cochabamba, Bolivia
³⁶Servicio de Hematologia, Caja Nacional de Salud - Hospital de Especialidades Materno Infantil La Paz, La Paz, Bolivia (Plurinational State of)
³⁷Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia
³⁸Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina
³⁹Hospital Israelita Albert Einstein, São Paulo, Brazil
⁴⁰Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴¹George Washington University Cancer Center, Washington, DC
⁴²Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴³Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA

Mahmoud Aldyab^1* and Mohammed Shiekhmohammed, MD^2*

¹Albany Medical center, Albany, NY
²Pathology, Albany Medical Center, Albany, NY

Miaoyan Zhang^1*, Xinxin Cao, MD^1*, Dao-Bin Zhou^1*, Lu Zhang, MD^1* and Jian Li, MD²

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
²Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

Huimin Zhang, BS^1,2*, Ya Zhang, MD^1,2*, Xiangxiang Zhou, MD^1,2*, Xiang Sun, BS^1,2*, Yang Han, MM^1*, Xinting Hu, MM^1,2*, Xiaoya Yun, BS^1,2* and Xin Wang, MD, PhD^1,2

¹Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China